Colinz Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Colinz Laboratories has a total shareholder equity of ₹85.3M and total debt of ₹4.6M, which brings its debt-to-equity ratio to 5.4%. Its total assets and total liabilities are ₹110.1M and ₹24.8M respectively. Colinz Laboratories's EBIT is ₹4.7M making its interest coverage ratio -3.6. It has cash and short-term investments of ₹63.5M.
Key information
5.4%
Debt to equity ratio
₹4.60m
Debt
Interest coverage ratio | -3.6x |
Cash | ₹63.47m |
Equity | ₹85.32m |
Total liabilities | ₹24.77m |
Total assets | ₹110.09m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 531210's short term assets (₹84.9M) exceed its short term liabilities (₹22.5M).
Long Term Liabilities: 531210's short term assets (₹84.9M) exceed its long term liabilities (₹2.2M).
Debt to Equity History and Analysis
Debt Level: 531210 has more cash than its total debt.
Reducing Debt: 531210's debt to equity ratio has reduced from 11.6% to 5.4% over the past 5 years.
Debt Coverage: 531210's debt is well covered by operating cash flow (87.5%).
Interest Coverage: 531210 earns more interest than it pays, so coverage of interest payments is not a concern.